A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
NCT ID: NCT00002117
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
528 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zidovudine
Zalcitabine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV infection.
* CD4 count 100 - 500 cells/mm3.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Foundation Hosp
Harbor City, California, United States
Kaiser Permanente Med Ctr
Los Angeles, California, United States
Sharp Rees - Stealy Med Group
San Diego, California, United States
UCSF - San Francisco Gen Hosp
San Francisco, California, United States
Denver Public Health Dept / Disease Control Services
Denver, Colorado, United States
Howard Univ
Washington D.C., District of Columbia, United States
Veterans Administration Med Ctr
Washington D.C., District of Columbia, United States
Miami Veterans Administration Med Ctr
Miami, Florida, United States
Univ of Miami School of Medicine
Miami, Florida, United States
Intergrated Care Ctr
Atlanta, Georgia, United States
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois, United States
Univ of Kansas School of Medicine
Wichita, Kansas, United States
New England Med Ctr
Boston, Massachusetts, United States
St Paul Ramsey Med Ctr / HIV Program Office
Saint Paul, Minnesota, United States
Washington Univ
St Louis, Missouri, United States
Univ of New Mexico School of Medicine
Albuquerque, New Mexico, United States
SUNY / Health Sciences Ctr at Brooklyn
Brooklyn, New York, United States
Saint Luke's - Roosevelt Hosp Ctr
New York, New York, United States
Bronx Veterans Affairs Med Ctr
The Bronx, New York, United States
Ohio State Univ Hosp Clinic
Columbus, Ohio, United States
Oregon Health Sciences Univ
Portland, Oregon, United States
N Texas Ctr for AIDS & Clin Rsch
Dallas, Texas, United States
Univ TX Galveston Med Branch
Galveston, Texas, United States
Dr Brian Buggy
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NV 14257
Identifier Type: -
Identifier Source: secondary_id
220A
Identifier Type: -
Identifier Source: org_study_id